How do I install the Endo Monitor Weight Waist Art skill?

Run npx skillmds@latest add dromlakhani/endo-monitor-weight-waist-art in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Endo Monitor Weight Waist Art safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: docs only. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Endo Monitor Weight Waist Art?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Endo Monitor Weight Waist Art free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Endo Monitor Weight Waist Art?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Endo Monitor Weight Waist Art by dromlakhani

Name: Endo Monitor Weight Waist Art
Rating: 4.5 (4 reviews)
Author: dromlakhani

Endo Monitor Weight Waist Art

Recommends regular monitoring of weight and waist circumference in patients receiving antiretroviral therapy due to unavoidable weight gain, redistribution, and associated cardiovascular risk. Triggered when a clinician asks, 'How often should I check weight and waist in this patient on ART?' or 'What parameters should I track to detect ART‑related weight changes?'

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Monitor weight and waist circumference in patients on antiretroviral therapy

STEP 1 — Gather Information

Collect baseline weight and waist circumference, current ART regimen and duration, cardiovascular risk factors (diabetes, hypertension, dyslipidemia), and any symptoms of lipodystrophy. Record these values for trend analysis.

STEP 2 — Rule In / Rule Out

Is the patient currently on antiretroviral therapy? If yes, proceed to ART‑specific weight/waist monitoring; if no, skip ART‑specific monitoring and follow general obesity screening guidelines.

STEP 3 — Classify or Stratify

Assess weight change (% change from baseline) and waist circumference change (cm change): stable (<3% weight gain and <5 cm waist increase), moderate (3‑5% weight gain or 5‑10 cm waist increase), or high (>5% weight gain or >10 cm waist increase). Assign risk level (low, moderate, high) to guide monitoring frequency and intervention.

STEP 4 — Decide

For low risk, repeat weight and waist in 6‑12 months; for moderate risk, repeat in 3 months and initiate lifestyle counseling; for high risk, repeat in 1‑3 months, intensify diet/exercise intervention, evaluate for ART switch after confirming virologic suppression, and consider referral to nutrition specialist.

Clinical Guardrails / Mimics / Pitfalls

Do not rely solely on BMI; waist circumference is essential to detect visceral adiposity. Avoid attributing weight gain exclusively to diet without reviewing ART regimen. Do not delay intervention until overt obesity develops. Avoid changing ART solely for weight gain without confirming viral suppression and exploring adherence.

Concrete Clinical Example

A 45‑year‑old man on TDF/FTC/EFV for 2 years presents for routine HIV visit. Baseline weight 78 kg, waist 92 kg. Current weight 86 kg (+10%, >5% threshold), waist 102 cm (+10 cm). He reports increased abdominal girth. Weight change >5% and waist increase >10 cm classify as high risk. Action: intensify diet/exercise counseling, consider switching to TAF‑based regimen after confirming viral suppression, and schedule weight/waist recheck in 1 month.

Source: Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2015, DOI: 10.1210/jc.2014-3415

---name: endo-monitor-weight-waist-artdescription: Recommends regular monitoring of weight and waist circumference in patients receiving antiretroviral therapy due to unavoidable weight gain, redistribution, and associated cardiovascular risk. Triggered when a clinician asks, 'How often should I check weight and waist in this patient on ART?' or 'What parameters should I track to detect ART‑related weight changes?'---# Monitor weight and waist circumference in patients on antiretroviral therapy## STEP 1 — Gather InformationCollect baseline weight and waist circumference, current ART regimen and duration, cardiovascular risk factors (diabetes, hypertension, dyslipidemia), and any symptoms of lipodystrophy. Record these values for trend analysis.## STEP 2 — Rule In / Rule OutIs the patient currently on antiretroviral therapy? If yes, proceed to ART‑specific weight/waist monitoring; if no, skip ART‑specific monitoring and follow general obesity screening guidelines.## STEP 3 — Classify or StratifyAssess weight change (% change from baseline) and waist circumference change (cm change): stable (<3% weight gain and <5 cm waist increase), moderate (3‑5% weight gain or 5‑10 cm waist increase), or high (>5% weight gain or >10 cm waist increase). Assign risk level (low, moderate, high) to guide monitoring frequency and intervention.## STEP 4 — DecideFor low risk, repeat weight and waist in 6‑12 months; for moderate risk, repeat in 3 months and initiate lifestyle counseling; for high risk, repeat in 1‑3 months, intensify diet/exercise intervention, evaluate for ART switch after confirming virologic suppression, and consider referral to nutrition specialist.## Clinical Guardrails / Mimics / PitfallsDo not rely solely on BMI; waist circumference is essential to detect visceral adiposity. Avoid attributing weight gain exclusively to diet without reviewing ART regimen. Do not delay intervention until overt obesity develops. Avoid changing ART solely for weight gain without confirming viral suppression and exploring adherence.## Concrete Clinical ExampleA 45‑year‑old man on TDF/FTC/EFV for 2 years presents for routine HIV visit. Baseline weight 78 kg, waist 92 kg. Current weight 86 kg (+10%, >5% threshold), waist 102 cm (+10 cm). He reports increased abdominal girth. Weight change >5% and waist increase >10 cm classify as high risk. Action: intensify diet/exercise counseling, consider switching to TAF‑based regimen after confirming viral suppression, and schedule weight/waist recheck in 1 month.**Source:** Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2015, DOI: 10.1210/jc.2014-3415

Frequently asked questions